The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells
- 11 August 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 57 (12), 1183-1190
- https://doi.org/10.1016/0024-3205(95)02064-p
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptideCell, 1993
- Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor proteinNeuron, 1993
- Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine ReceptorsScience, 1992
- Production of the Alzheimer Amyloid β Protein by Normal Proteolytic ProcessingScience, 1992
- Isolation and quantification of soluble Alzheimer's β-peptide from biological fluidsNature, 1992
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridinesJournal of Medicinal Chemistry, 1992
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Cleavage of Amyloid β Peptide During Constitutive Processing of Its PrecursorScience, 1990
- Evidence that β-Amyloid Protein in Alzheimer's Disease Is Not Derived by Normal ProcessingScience, 1990